Amerikanische Gesellschaft für Hirudotherapie

Cell dynamics during cocoon secretion in the aquatic leech, Theromyzon tessulatum

Reproductive biology published in Tissue Cell (2008)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikSayers CW, Coleman J, Shain DH · Tissue & cell, 2008

Abstract

One distinguishing feature of clitellate annelids is the presence of specialized segments comprising the clitellum, whose primary function is to secrete a cocoon. Using histological analyses, we have documented cell types (I-V) and cellular processes associated with cocoon secretion in the aquatic leech, Theromyzon tessulatum. Our data indicate that the bulk of the cocoon's biomass arises from precursor cells of a single type that hypertrophy and proliferate approximately 1 week prior to egg laying, and then differentiate into either of two cell types (i.e., Type II or Type III) depending on their position within the clitellum. Type II cells are concentrated along the lateral edges and venter of the clitellum and secrete alcian blue-staining granules that form opercula (i.e., glue-like material that seals both cocoon ends), while Type III cells populate the dorsal midline and secrete azocarmine-staining granules that build the cocoon wall. Both cell types occupy spaces between deep muscle layers and extend long-neck tubules to the surface epithelium as they fill with granules a few days prior to egg laying. Other cell types appear to make minor contributions to the cocoon (e.g., Type I, Type IV) or have supporting or signaling roles (e.g., Type V). Our observations suggest that post-translational modification (i.e., glycosylation) of the same core protein(s) distinguishes the granules of Type II/III cells, and that the default state of the Type II/III precursor may be evolutionarily linked to secretory cells in basal polychaetes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, U.S. Gov't, Non-P.H.S.
Indexed MeSH termsAnimalsEpithelial CellsEpitheliumFemaleLeechesMicroscopy, Electron, ScanningOvipositionReproductionSecretory Vesicles

Zusammenfassung

Histological characterization of five distinct clitellum cell types (I–V) in Theromyzon tessulatum during cocoon production. Type II cells secrete operculum granules; Type III cells secrete cocoon-wall granules, both arising from a common precursor.

Warum dies für die Hirudotherapie relevant ist

The study used histological analysis to map cell types and processes during cocoon secretion in the aquatic leech Theromyzon tessulatum. It reports that one precursor cell type hypertrophies and differentiates into Type II cells, which secrete operculum-forming granules, or Type III cells, which secrete cocoon-wall granules, with minor or supporting roles from other cell types. It also suggests that glycosylation of similar core proteins may distinguish the two secretory products. For ASH, this is indirect basic leech secretory-cell biology only; the findings are descriptive in one species and do not address salivary anticoagulants, the therapeutic secretome, or hirudotherapy.

Zitation

Cell dynamics during cocoon secretion in the aquatic leech, Theromyzon tessulatum (Annelida: Clitellata: Glossiphoniidae).

Sayers CW, Coleman J, Shain DH · Tissue & cell, 2008

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.